Mikko Niemi
Department of Clinical Pharmacology
University of Helsinki and Helsinki University Central Hospital
Helsinki
Finland
Name/email consistency: high
- Role of OATP transporters in the disposition of drugs. Niemi, M. Pharmacogenomics (2007)
- Association of genetic polymorphism in ABCC2 with hepatic multidrug resistance-associated protein 2 expression and pravastatin pharmacokinetics. Niemi, M., Arnold, K.A., Backman, J.T., Pasanen, M.K., Gödtel-Armbrust, U., Wojnowski, L., Zanger, U.M., Neuvonen, P.J., Eichelbaum, M., Kivistö, K.T., Lang, T. Pharmacogenet. Genomics (2006)
- Itraconazole, gemfibrozil and their combination markedly raise the plasma concentrations of loperamide. Niemi, M., Tornio, A., Pasanen, M.K., Fredrikson, H., Neuvonen, P.J., Backman, J.T. Eur. J. Clin. Pharmacol. (2006)
- SLCO1B1 polymorphism and sex affect the pharmacokinetics of pravastatin but not fluvastatin. Niemi, M., Pasanen, M.K., Neuvonen, P.J. Clin. Pharmacol. Ther. (2006)
- Polymorphic organic anion transporting polypeptide 1B1 is a major determinant of repaglinide pharmacokinetics. Niemi, M., Backman, J.T., Kajosaari, L.I., Leathart, J.B., Neuvonen, M., Daly, A.K., Eichelbaum, M., Kivistö, K.T., Neuvonen, P.J. Clin. Pharmacol. Ther. (2005)
- Coadministration of gemfibrozil and itraconazole has only a minor effect on the pharmacokinetics of the CYP2C9 and CYP3A4 substrate nateglinide. Niemi, M., Backman, J.T., Juntti-Patinen, L., Neuvonen, M., Neuvonen, P.J. Br. J. Clin. Pharmacol (2005)
- Glyburide and glimepiride pharmacokinetics in subjects with different CYP2C9 genotypes. Niemi, M., Cascorbi, I., Timm, R., Kroemer, H.K., Neuvonen, P.J., Kivistö, K.T. Clin. Pharmacol. Ther. (2002)